First Trust Nasdaq Pharmaceuticals ETF
FTXH
9 hedge funds and large institutions have $1.22M invested in First Trust Nasdaq Pharmaceuticals ETF in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
13% more funds holding
Funds holding: 8 → 9 (+1)
5% more capital invested
Capital invested by funds: $1.16M → $1.22M (+$61K)
5.2% less ownership
Funds ownership: 21.7% → 16.5% (-5.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$351K |
| 2 |
LPL Financial
San Diego,
California
|
+$321K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$3.91K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.91K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$21 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$568K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$54K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $655K | +$351K | +16,915 | +120% |
|
|
2
LPL Financial
San Diego,
California
| $327K | +$321K | +15,466 | New |
|
|
SMFS
3
Squar Milner Financial Services
Irvine,
California
| $119K | – | – | – |
|
4
Bank of America
Charlotte,
North Carolina
| $44K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $34K | +$1.91K | +92 | +6% |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| $19K | +$3.91K | +188 | +27% |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $14K | – | – | – |
|
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $8K | -$54K | -2,600 | -87% |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$568K | -26,559 | Closed |
|
|
10
Wells Fargo
San Francisco,
California
| – | +$21 | +1 | New |
|
FTXH Hedge Fund Activity: Q2 2019 in Review
9 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) for Q2 2019, worth a combined $1.22M — up 5.3% from $1.16M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new FTXH positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $351K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $568K sold.
- 9 institutional investors held First Trust Nasdaq Pharmaceuticals ETF (FTXH) as of Q2 2019, up from 8 in Q1 2019.
- Funds reported $1.22M of First Trust Nasdaq Pharmaceuticals ETF stock for Q2 2019, up 5.3% quarter-over-quarter.
- 2 funds opened new First Trust Nasdaq Pharmaceuticals ETF positions in Q2 2019 and 1 closed out, a net change of +1 holder.
- The largest First Trust Nasdaq Pharmaceuticals ETF buyer in Q2 2019 was Jane Street, an estimated $351K added.
- The largest First Trust Nasdaq Pharmaceuticals ETF seller in Q2 2019 was Susquehanna International Group, an estimated $568K sold.
Based on aggregated 13F filings for Q2 2019.